论文部分内容阅读
目的观察依达拉奉治疗脑梗死疗效。方法将30例脑梗死患者随机分成两组,治疗组15例,对照组15例,对照组应用胞二磷胆碱,治疗组加用依达拉奉注射液。将两组治疗前、治疗2周的临床神经功能缺损程度及疗效评分。结果治疗前两组评分比较差异无统计学意义,治疗2周差异有显著性,治疗组优于对照组。结论治疗组明显改善临床神经功能,提高疗效,无不良反应。
Objective To observe the therapeutic effect of edaravone on cerebral infarction. Methods Thirty patients with cerebral infarction were randomly divided into two groups: treatment group (15 cases) and control group (15 cases), citicoline (control group), and edaravone (injection). The clinical neurological deficits and efficacy scores of two groups before treatment and two weeks after treatment were compared. Results There was no significant difference in score between the two groups before treatment, the difference was significant at 2 weeks after treatment, and the treatment group was superior to the control group. Conclusion The treatment group significantly improved clinical neurological function, improve efficacy, no adverse reactions.